Client Coverage

Enveric Biosciences to out-license psilocin prodrug to MindBio

Pharmaceutical Technology

Psychedelics for Depression: MindBio and Enveric’s Joint Efforts

The Dales Report

Microdosing For Depression: Psychedelics Biotech Signs $66.5M Non-Binding Deal To Out-License Novel Psilocin Prodrug Candidate

Benzinga

Finding The Right Patients For Ketamine Clinical Trials

Clinical Trials

Rethinking Mental Health: How Emerging Therapies Are Changing the Game

Newsweek

A Pioneering Push in Cancer Treatment: Enveric Biosciences Advances with Cannabinoid Therapies

Microdose

Cannabinoids With Chemotherapy For Breast Cancer: Psychedelics Biotech Inks $61M License Deal For Patented Methods

Benzinga

Clinical Trial To Assess LSD Microdosing For PMS

HighTimes

Bryan Johnson Eats This Treat Every Day. Should You?

Healthiness

MindBio to test LSD to treat menstrual mood symptoms

Green Market Report

Unlocking New Horizons: Enveric Biosciences’ Strategic Moves in Biotechnology

Microdose

LSD Microdosing For PMS? After Confirming Antidepressant Effects, Clinical Trials Will Assess If It Addresses Mood Issues

Benzinga

What Is CBN, and What’s the Difference Between CBN and CBD For Sleep?

Sleepopolis

Take-Home Microdosing Trial Studies Sub-Hallucinogenic For Depression

Clinical Leader

MindBio’s MB22001 Study Shows Promise for Improved Sleep

The Dales Report

Bucking Convention: How Analog Ibogaine Could Help Conquer CNS Disorders

Drug Discovery Online

The Microdosing Effect: Connecting the Dots Between Anecdote and Evidence

Psychedelics Today

Western diet may cause long-lasting memory damage to growing brains

Medical News Today

Viral hack to consume every vitamin with just two foods approved by nutritionist

The Focus

Small but mighty: The role of small-molecule drugs in disease treatment

LaBiotech

EXCLUSIVE: Enveric Biosciences Announces Non-Binding Deals To License Out Three Types of Drug Compounds

Benzinga

From LSD to healing minds: Where are we standing in psychedelic drug development?

LaBiotech

Supplying Complex, Controversial, And Intercontinental Clinical Trials

Clinical Leader

Study: Taking a Daily Fiber Supplement May Help Improve Brain Function in Older Adults

Health

Pharma with a Side of Therapy

Oprah Daily

Mental Health Sector Is Adopting AI-Powered Apps for Accessible Care

PYMNTS

Unlocking Market Potential: Leveraging Big Data Analytics to Revolutionize Depression Research

Best Stocks

30 Psychedelics Executives, Scientists & Influencers To Watch In 2024 And Beyond

Benzinga

Enveric’s EB-003 selected as lead candidate for mental health disorders

Pharmaceutical Technology

Wonderland Conference Miami: Bridging Psychedelics And Overall Wellness

Benzinga

Recent Coverage: Psychedelics and health at the forefront for upcoming Wonderland Miami

GreenState

Unlocking Market Potential: Leveraging Big Data Analytics to Revolutionize Depression Research

Stocks Today

PurMinds: 'A Neuroscience Biopharma Company With A Robust Psychedelic Strategy'

Microdose

Joseph Tucker – Drugs for Neuroplasticity

The Mindfulness Experience Podcast

Psilocin prodrug receives USPTO development approval

Psychedelic Health

Biotech firm receives patent for psilocybin-derived mental health therapeutics

Helio

Psilocybin-Based Drug Candidate Gains Patent

High Times

U.S. approval for psychedelic drug MDMA nears after success in clinic

LA Biotech

Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives

Benzinga

First LSD Microdosing Trials Show Promise

LA Weekly

Has British biotech outgrown the Square Mile?

Proactive

Biotech firm receives patent for psilocybin-derived mental health therapeutics 

Helio

Psilocybin-Based Drug Candidate Gains Patent

High Times

U.S. approval for psychedelic drug MDMA nears after success in clinic

Labiotech

Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives

Benzinga

Enveric Receives Patent For Psilocybin Molecules

The Green Market Report

‘We spark curiosity’: how the psychedelics industry is taking on Davos

The Guardian

10 Psychedelics CEOs To Pay Attention To In 2022

Benzinga

In Psychedelic Investing, Long-Term Thinking Is Key

Microdose

Psychedelic Companies With Solid Fundamentals Will Survive A Downturn In The Recession-Ridden Market

Benzinga

Trail-blazing psychedelic medicine? The clinical trial treating depression with tiny doses of LSD

NZ Herald

Looking At Psychedelics For Cancer Patients Mental Health

Green Market Report

3 Microdosing Clinical Trials to Keep an Eye On. 

Psychedelic Spotlight

Why scientists want to create psychedelics that give better trips

National Geographic

Phase 1 Microdosing LSD Study Yields Positive Results

TDR

First LSD Microdosing Trials Show Promise​

LA Weekly